Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q84859618)
Watch
English
Belatacept
scientific article published on 31 August 2011
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21878974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
title
Belatacept
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21878974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
author
Peter Kirkpatrick
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21878974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
author name string
Flavio Vincenti
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21878974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
Argyris Dritselis
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21878974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
publication date
31 August 2011
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21878974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
published in
Nature Reviews Drug Discovery
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21878974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
volume
10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21878974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
issue
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21878974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
page(s)
655-656
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21878974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
exact match
https://scigraph.springernature.com/pub.10.1038/nrd3536
0 references
cites work
Novel strategies in immunosuppression: issues in perspective
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD3536
retrieved
31 March 2020
Long-term renal allograft survival in the United States: a critical reappraisal
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD3536
retrieved
31 March 2020
Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD3536
retrieved
31 March 2020
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD3536
retrieved
31 March 2020
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD3536
retrieved
31 March 2020
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD3536
retrieved
31 March 2020
Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD3536
retrieved
31 March 2020
Identifiers
DOI
10.1038/NRD3536
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21878974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
PubMed publication ID
21878974
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21878974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit